DNLZY (DNLZY) Stock Price & Analysis
DNLZY (DNLZY) rose 5.34% to USD 2.76 as of June 10, 2026 at 02:28 UTC, according to Nexqual real-time market data.
DNLZY last closed at USD 2.62; the session ranged USD 2.76–2.76 on volume of 227 shares. Market capitalization is $4.84B, with a 52-week range of USD 1.4–2.77 (PNK). Source: Nexqual, June 10, 2026 at 02:28 UTC.
Key Statistics (as of June 10, 2026 at 02:28 UTC)
| Price | USD 2.76 |
|---|---|
| Change | ▲ 5.34% (up) |
| Previous Close | USD 2.62 |
| Open | USD 2.76 |
| Day Range | USD 2.76 – 2.76 |
| 52-Week Range | USD 1.4 – 2.77 |
| Volume | 227 shares |
| Market Cap | $4.84B |
| Exchange | PNK |
Technical Analysis (DNLZY)
Nexqual's technical model rates DNLZY "BUY" based on 4 bullish and 1 bearish signals across 123 daily candles, as of June 10, 2026 at 02:28 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 52.3 (neutral) |
| vs SMA50 | Above (USD 2.36) |
| MACD | 0.08 (positive) |
Analyst Ratings (DNLZY)
Wall Street analysts rate DNLZY "None", per Nexqual as of June 10, 2026 at 02:28 UTC.
| Consensus Rating | None |
|---|
Earnings (DNLZY)
Source: Nexqual, June 10, 2026 at 02:28 UTC.
Financials & Fundamentals (DNLZY)
| Total Revenue | $3.91B |
|---|---|
| Revenue Growth (YoY) | +9.20% |
| Gross Margin | +56.90% |
| Operating Margin | +11.23% |
| Profit Margin | -1.04% |
| ROE | +5.76% |
| Debt / Equity | 39.65 |
| Current Ratio | 1.27 |
| Total Cash | $175.40M |
| Total Debt | $1.60B |
| Free Cash Flow | $831.52M |
Source: Nexqual, June 10, 2026 at 02:28 UTC.
Financial Health Score (DNLZY)
Nexqual rates DNLZY's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 02:28 UTC.
| Growth | Weak — Revenue -0% YoY (annual), declining |
|---|---|
| Profitability | Strong — Gross margin 57%, operating 11% |
| Balance Sheet | Solid — $175M cash vs $1.60B debt |
| Cash Flow | Strong — FCF $832M, 16% margin |
| Efficiency | Mixed — ROE 6%, ROA 5.0% |
Ownership (DNLZY)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 1.75B |
| Float | 1.60B |
Source: Nexqual, June 10, 2026 at 02:28 UTC.
Leadership (DNLZY)
DNLZY is led by Mauro Neves de Moraes, MD, CEO & Director, per Nexqual as of June 10, 2026 at 02:28 UTC.
| MD, CEO & Director | Mauro Neves de Moraes |
|---|---|
| Chief Financial Officer | Nitesh Naidoo A.C.M.A., BCOMPT |
| President of Dyno Nobel Americas | Greg Hayne B.Com., M.A.I.C.D. |
| Vice President of Investor Relations | Tom Dixon |
| President of EMEA & LATAM | Richard Brown |
Major Backers & Investors (DNLZY)
Notable institutional backers of DNLZY include VanEck ETF Trust-VanEck Agribusiness ETF, according to Nexqual as of June 10, 2026 at 02:28 UTC.
Active Investors
| Investor | Stake |
|---|---|
| VanEck ETF Trust-VanEck Agribusiness ETF | 0.2% |
Source: Nexqual, June 10, 2026 at 02:28 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| HYPMY | Hypera SA | USD 3.96 | ▼ 5.71% |
| FUPBY | FUCHS SE | USD 11.17 | ▲ 1.45% |
| SOMMY | Sumitomo Chemical Co., Ltd. | USD 19.05 | ▲ 4.16% |
| JMPLY | Johnson Matthey plc | USD 54.42 | ▼ 5.41% |
| NDEKY | Nitto Denko Corp. | USD 17.86 | ▼ 3.04% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:28 UTC. This page is informational and not investment advice.